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We previously reported that the xanthine nucleotide
binding Goa mutant, GoaX, inhibited the activation of
Gi-coupled receptors. We constructed similar mutations
in G11a and G16a and characterized their nucleotide
binding and receptor interaction. First, we found that
G11aX and G16aX expressed in COS-7 cells bound xan-
thine 5*-O-(thiotriphosphate) instead of guanosine 5*-O-
(thiotriphosphate). Second, we found that G11aX and
G16aX interacted with bg subunits in the presence of
xanthine diphosphate. These experiments demon-
strated that G11aX and G16aX were xanthine nucleotide-
binding proteins, similar to GoaX. Third, in COS-7 cells,
both G11aX and G16aX inhibited the activation of Gq-
coupled receptors, whereas only G16aX inhibited the ac-
tivation of Gi-coupled receptors. Therefore, when in the
nucleotide-free state, empty G11aX and G16aX appeared
to retain the same receptor binding specificity as their
wild-type counterparts. Finally, we found that GoaX,
G11aX, and G16aX all inhibited the endogenous thrombin
receptors and lysophosphatidic acid receptors in
NIH3T3 cells, whereas G11aX and G16aX, but not GoaX,
inhibited the activation of transfected m1 muscarinic
receptor in these cells. We conclude that these empty G
protein mutants of Goa, G11a, and G16a can act as dom-
inant negative inhibitors against specific subsets of G
protein-coupled receptors.
Heterotrimeric G protein signaling pathways are commonly
used to transduce signals across cell membranes in eukaryotic
cells. G proteins contain three subunits, a, b, and g, and can be
activated by hundreds of seven-transmembrane receptors.
Binding of agonist to receptor activates the receptor, which
then catalyzes the exchange of GTP for GDP bound to G protein
a subunits. Activated GTP-bound a subunits and free bg sub-
units regulate a variety of cellular effectors, including enzymes
and ion channels (1–3). G protein a subunits can be divided into
four families: Gs, Gi (Gi, Go, and transducin), Gq (Gq, G11, G14,
and G16), and G12 (G12 and G13). Some G protein-coupled re-
ceptors activate only one family of G proteins, whereas other
receptors may activate multiple families of G proteins. G16 and
its mouse homologue G15 behave promiscuously; they can be
activated by all classes of G protein-coupled receptors (4).
We recently reported that the xanthine nucleotide binding
Goa mutant, GoaX (a double mutant of Goa, D273N/Q205L) can
interact with appropriate receptors on the membrane (5, 6).
GoaX was regulated by xanthine nucleotides instead of guanine
nucleotides. The empty form (nucleotide-free) of GoaX has been
shown to form a stable complex with Go-coupled receptors and
to inhibit the cognate receptor by competing with endogenous
wild-type G proteins. In the present study, we investigated the
functions of similar mutants in another G protein family. We
found that both G11aX (G11aDN/QL) and G16aX (G11aDN/QL)
were xanthine nucleotide-binding proteins. They bound
XTPgS, but not GTPgS. These mutant proteins were also able
to bind bg subunits only in the presence of XDP. In the nucle-
otide-free state, they interacted with their appropriate recep-
tors and inhibited activation. Furthermore, G11aX and G16aX
retained the same receptor binding specificity of the wild-type
proteins. G11aX only inhibited Gq-coupled receptors, but not
Gi-coupled receptors, whereas G16aX was able to inhibit recep-
tors from both families. These results suggest that as with
GoaX, G11aX, and G16aX can be used as dominant inhibitors
against a subset of G protein-coupled receptors.
EXPERIMENTAL PROCEDURES
Materials—Purified bovine retinal transducin bg were generous gifts
from Dr. O. Nakanishi (Division of Biology, Caltech). Xanthine nucleo-
tides and guanine nucleotides were from Sigma. Radioactive
[35S]ATPgS,1 [35S]GTPgS, and [3H]quinuclidinylbenzilate were from
NEN Life Science Products.
Mutagenesis of G11a and G16a—The D277N mutation was introduced
in both wild-type G11a and the activated mutant G11aQ209L. The
D280N mutation was introduced in both wild-type G16a and the acti-
vated G16aQ213L. The site-specific mutagenesis was conducted by po-
lymerase chain reaction using oligonucleotide TTCCTCAACAAGAAG-
GACCTTCTAGAAGAC for G11a and TTTCTCAACAAAACCGACATC-
CTGGAGGAGAAAATCCC for G16a. The cDNAs were subcloned into
the pCIS vector under the control of a CMV promoter.
Expression and Purification of His6-tagged Goa—Both wild-type Goa
and mutant GoaX were subcloned into the Escherichia coli expression
vector pET-15b (Novagen) with a His6 tag at the N terminus (5). The
recombinant proteins were expressed and purified as described previ-
ously. The His6-tagged proteins were purified over a Ni
21-nitrilotriace-
tic acid column according to the protocol provided by the manufacturer
(Novagen, Inc.). Purified proteins were stored in TED buffer (20 mM
Tris-HCl, pH 8.0, 1 mM EDTA, and 1 mM dithiothreitol) with 0.1 mM
MgCl2.
Membrane Preparation from Baculovirus-infected Sf9 Cells—Sf9
cells were grown and infected with recombinant baculoviruses encoding
m2 MAChR (7, 8). Membranes of the infected cells were prepared as
described. Infected cells were centrifuged and resuspended at ,107
cells/ml in HME/PI buffer (20 mM NaHepes, pH 8.0, 2 mM MgCl2, 1 mM
EDTA, 0.1 mM phenylmethylsulfonyl fluoride, 2 mg/ml aprotinin, and 10
mg/ml leupeptin). The cell suspension was homogenized by 10 strokes in
a glass homogenizer followed by passing through a 27-gauge hypoder-
mic needle several times. The homogenate was briefly centrifuged at
3,000 3 g for 10 min, and then the supernatant was collected and
centrifuged at 30,000 3 g for 30 min. The pellet was washed once with
HME/PI, and the final pellet was resuspended in HME/PI at a protein
concentration of 5 mg/ml.
Synthesis of XTPgS—XTPgS was synthesized from XDP and ATPgS
with nucleotide diphosphate kinase as described previously (9). To
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
1 The abbreviations used are: ATPgS, adenosine 59-O-(thiotriphos-
phate); GTPgS, guanosine 59-O-(thiotriphosphate); XTPgS, xanthine
59-O-(thiotriphosphate); MAChR, muscarinic cholinergic receptor;
DMEM, Dulbecco’s modified Eagle’s medium; LPA, lysophosphatidic
acid; TRH, thyrotropin-releasing hormone; SRF, serum response factor;
SRE, serum response element; PLC, phospholipase.
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produce 35S-labeled XTPgS, the reaction contained 10 mM XDP, 1 mM
[35S]ATPgS, and 10 units nucleotide diphosphate kinase (Sigma) in 100
ml of nucleotide diphosphate kinase buffer (1 mM MgCl2, 5 mM dithio-
threitol, and 20 mM Tris-HCl, pH 8.0). The mixture was incubated at
room temperature for 2 h. The resulting concentration of [35S]XTPgS
was about 1 mM (1 mCi/pmol). The radiochemical purity of XTPgS was
monitored by TLC on Avicel/DEAE plates (Analtech) in 0.07 N HCl.
Receptor-stimulated GTPgS Binding of Purified Goa—Binding of
[35S]GTPgS to recombinant Goa was performed as described previously
(5, 6). 0.5 mg of purified Goa was first incubated with 1 mg of transducin
bg and 100 mg of m2 MAChR membrane in TED buffer with 10 mM GDP,
0.1 mM MgCl2, and 1 mM ATP for 0.5 h. The reaction was started with
the addition of 0.1 mM GTPgS (20,000 cpm/pmol) and 100 mM carbachol.
For the time course experiments, 20-ml aliquots were withdrawn from a
200-ml reaction, diluted 10-fold with ice-cold TED buffer containing 0.1
mM MgCl2, filtered through 45-mm nitrocellulose, washed, and dried.
The amount of bound radioactivity was determined by scintillation
counting.
COS-7 Cell Culture and Transfection—COS-7 cells were cultured in
DMEM containing 10% fetal bovine serum. 1 3 105 cells/well were
seeded in 12-well plates 1 day before transfection. All transfection
assays contained a total amount of 1 mg of DNA, and pCIS encoding
b-galactosidase was used to maintain a constant amount of DNA. To
each well, 1 mg of DNA was mixed with 5 ml of LipofectAMINE (Life
Technologies, Inc.) in 0.5 ml of Opti-MEM (Life Technologies, Inc.), and
5 h later, 0.5 ml of 20% fetal calf serum in DMEM was added to the
medium. After 48 h, cells were assayed for inositol phosphate levels as
described previously (10, 11).
Immunoprecipitation of XTPgS-bound G11aX and G16aX—COS-7
cells were transfected with G11aX and G16aX 2 days before being lysed
in the RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet
P-40, 0.5% deoxycholate, 0.1% SDS) with 2 mM MgCl2, 1 mM EDTA, and
protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 2 mg/ml
aprotinin, and 10 mg/ml leupeptin). The lysate was centrifuged at
12,000 3 g for 10 min, and the supernatant was incubated with 0.1 mM
[35S]XTPgS or [35S]GTPgS (20,000 cpm/ml) for 1 h at room temperature.
G11aX and G16aX proteins were then immunoprecipitated using appro-
priate antibodies and protein A-Sepharose (Sigma). The amount of
radioactive nucleotide in the immunoprecipitates was determined by
scintillation counting.
Permeabilization of COS-7 Cell Membranes—Membranes of trans-
fected COS-7 cells were permeabilized as described (5). Cells were
washed and incubated in 200 ml of permeabilization solution consisting
of 115 mM KCl, 15 mM NaCl, 0.5 mM MgCl2, 20 mM Hepes-NaOH, pH 7,
1 mM EGTA, 100 mM ATP, 0.37 mM CaCl2 (to give a free Ca
21 concen-
tration of 100 nM), and 200 units/ml a-toxin with or without 0.1 mM XDP
for 10 min at 37 °C. Then 2 ml of 1 M LiCl was added before the inositol
phosphate assay.
NIH3T3 Cell Culture and Transfection—NIH3T3 cells were main-
tained in DMEM containing 10% calf serum. 1 3 105 cells/well were
seeded into 24-well plates 1 day before transfection. Total of 1 mg/well
of DNA, including 0.2 mg of pSRF-Luc reporter plasmid (Strategene,
Inc.), were used to transfect cells with Superfect (Life Technologies,
Inc.), following the manufacturer’s recommendations. Plasmid of pCIS
encoding b-galactosidase was used to maintain a constant amount of
DNA for each well.
Luciferase Assay—Transfected NIT3T3 cells were maintained in
DMEM containing 0.05% calf serum overnight and then were stimu-
lated with 500 nM of LPA or 1 unit/ml of thrombin in the same medium
for 6 h before cell extracts were collected to determine the activity of
luciferase. The luciferase assay was performed following the protocol of
Luciferase Assay System from Promega. The activity of luciferase was
determined by measuring luminescence intensity using a luminometer
(Monolight 2010 from Analytical Luminescence Laboratory).
RESULTS
Inhibition of GoaX to GTPgS Binding of Wild-type Goa Stim-
ulated by m2 Muscarinic Receptors—We have previously
shown that GoaX inhibited the activation of m2 muscarinic
receptors (m2 MAChR) in transfected COS-7 cells (6). To test
inhibition of m2 MAChR more directly, we asked whether
preincubation of receptor with GoaX inhibited the binding of
GTPgS to wild-type Goa facilitated by activated m2 MAChR in
vitro. Recombinant m2 MAChR from Sf9 cells has been shown
to stimulate the binding of GTPgS to wild-type Goa 2–3-fold in
response to muscarinic agonists (7, 8). We infected Sf9 cells
with recombinant baculoviruses encoding m2 MAChR and pre-
pared membranes. The concentration of receptor in isolated
membranes was about 20 pmol/mg of membrane protein, de-
termined from [3H]QNB binding. In the control experiments,
we reconstituted purified Goa with the transducin b1g1 sub-
units and Sf9 cell membranes containing m2 MAChR and then
assayed the binding of GTPgS to Goa upon activation with the
muscarinic agonist carbachol. We found that carbachol accel-
erated the binding of GTPgS to Goa (Fig. 1A). Then we coincu-
bated different amounts of purified GoaX in similar experi-
FIG. 1. GoaX inhibits the GTPgS binding of wild-type Goa stim-
ulated by m2 MAChR. A, 100 mg of m2 MAChR membranes was
incubated with 0.5 mg of Goa, 1 mg of bg, 10 mM GDP, and indicated
amount of GoaX in TEDM buffer (20 mM Tris-HCl, pH 8.0, 1 mm EDTA,
1 mM dithiothreitol, and 1 mm MgCl2) for 20 min at room temperature
and then the mixture was diluted 10-fold with TEDM buffer containing
0.1 mM [35S]GTPgS (20,000 cpm/pmol) and 100 mM carbachol at time 0.
20-ml aliquots were withdrawn and assayed for the bound nucleotides at
the indicated times. B, 0.5 mg of wild-type Goa was preincubated with
100 mg of m2 MAChR membranes and 3 mg of GoaX under indicated
conditions and then subjected to the similar GTPgS binding assay as in
A. Only data at 20 min were shown as the percentage of maximum
binding.
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ments and found that GoaX attenuated the m2 MAChR-
catalyzed activation of GTPgS binding to Goa. The inhibitory
effect of GoaX was proportional to the amount of GoaX added
(Fig. 1A). This result is consistent with our previous finding
that GoaX forms a stable complex with m2 MAChR. Since we
have also demonstrated that the interaction between GoaX and
m2 MAChR can be abolished by either XDP or XTP (6), we then
tested whether XDP or XTP could relieve the inhibitory effect
of GoaX. As expected, GoaX did not inhibit the activation of m2
MAChR in the presence of XTP. However, GoaX was able to
inhibit the binding of GTPgS to Goa when XDP was present
(Fig. 1B). This is not surprising because GoaX is able to bind bg
in the presence of XDP. We conclude that GoaX competes with
wild-type Goa for bg subunits and inhibits the activation of Goa
by receptor. This is also consistent with the fact that the acti-
vation of Goa by m2 MAChR requires bg (Fig. 1B).
Binding of XTPgS to G11aX and G16aX—To test whether the
DN mutation of the conserved NKXD motif in other G protein
a subunits also generates xanthine nucleotide-binding pro-
teins, we introduced the mutation in both wild-type G11a and
G16a and into their activated QL mutant cDNA. We then ex-
pressed the mutant proteins G11aDN (G11aD277N), G11aX
(G11aD277N/Q209L), G16aDN (G16aD280N), and G16aX
(G16aD280N/Q213L) in COS-7 cells (Fig. 2, A and B). Unlike
Goa, large quantities of active recombinant proteins of G11a
and G16a are not easily expressed and purified from E. coli.
Thus we decided to test the nucleotide binding of the mutant
proteins in COS-7 cell lysates. After incubating with the radio-
active GTPgS or XTPgS, we immunoprecipitated the mutant
proteins and assayed bound radioactive nucleotide. We found
that G11aX and G16aX bound XTPgS instead of GTPgS,
whereas wild-type G11a and G16a preferred GTPgS (Fig. 2, C
and D). Consistent with our previous finding that GoaX bound
xanthine nucleotides but not guanine nucleotides, whereas
GoaDN did not bind either nucleotides, we found that both
G11aDN and G16aDN did not show strong binding of either
[35S]GTPgS or [35S]XTPgS.
XDP-dependent bg Interaction of G11aX and G16aX—We pre-
viously showed that GoaX was able to bind bg subunits in the
presence of XDP (5). To test whether G11aX and G16aX also
shows XDP-dependent bg interaction, we assayed their binding
with bg in transfected COS-7 cells. In COS-7 cells, b1g2 is able
to activate PLCb2, and the activation of PLCb2 can be inhib-
ited by cotransfection with wild-type Goa because of competi-
tion for bg (5, 12). We cotransfected COS-7 cells with PLCb2,
b1, g2, and G11aX or G16aX and found that neither mutant
inhibited PLCb2 activity, whereas wild-type Goa did inhibit.
This experiment suggests that G11aX and G16aX do not bind bg
FIG. 2. XTPgS binding of G11aX and G16aX. In A and B, mutant
proteins of G11aX, G11aDN, G16aX, and G16aDN were expressed in
COS-7 cell and subjected to Western blots using antibodies against
G11a and G16a, respectively. In C and D, the lysates of transfected
COS-7 cells were incubated with indicated radioactive nucleotide for 1 h
at room temperature. The mutant protein was then immunoprecipi-
tated using appropriate antibodies and the amount of radioactive nu-
cleotide was determined.
FIG. 3. The interaction of G11aX and G16aX with bg in trans-
fected COS-7 cells is XDP-dependent. 1 3 105 cells/well were seeded
in a 12-well plate and then were transfected with cDNAs encoding the
indicated proteins the next day. The total amount of cDNA for each well
was adjusted to 1.0 mg by addition of CMV-LacZ cDNA. Cells were
labeled with [3H]inositol, and the levels of inositol phosphates were
determined after incubating cells with 200 units/ml of a-toxin with or
without 1024 M XDP.
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presumably because the intracellular concentration of XDP is
negligible (13) (Fig. 3). To deliver XDP into cells, we permeabi-
lized the cell membrane with a-toxin. After incubating trans-
fected COS-7 cells with a-toxin in the presence of XDP, we
found that both G11aX and G16aX inhibited PLCb2 activity
stimulated by bg (Fig. 3). In the similar experiments with
G11aDN and G16aDN, we did not see inhibition of the activa-
tion of PLCb2, even when XDP was present (Fig. 3). In the
control experiments, we found that a-toxin alone or a-toxin
followed by GDP or GTP addition did not affect the activity of
PLCb2 (data not shown). These experiments show that G11aX
and G16aX do not bind bg and interfere with its activation of
PLCb2 in the nucleotide-free state. However, when in the XDP-
bound form, G11aX and G16aX are able to sequester cellular bg
and inhibit its ability to activate PLCb2.
Dominant Negative Inhibition of G Protein-coupled Receptor
by Empty G11aX and G16aX—GoaX binds to members of the
Gi-coupled receptor family and has been shown to act as a
dominant inhibitor of Gi-coupled receptors (6). To test receptor
interaction of G11aX and G16aX, we assayed their ability to
inhibit the activation of G protein-coupled receptors in COS-7
cells. m1 muscarinic receptors (m1 MAChR) have been shown
to primarily activate the Gq family of G proteins (10). Activated
Gqa then stimulates PLCb isoforms to elevate cellular inositol
1,4,5-trisphosphate concentration. We cotransfected COS-7
cells with m1 MAChR and G11aX or G16aX and tested whether
the mutant proteins inhibited the activation of m1 MAChR by
competing with endogenous Gqa. We found that both G11aX
and G16aX were able to inhibit the activity of endogenous PLCb
isoforms stimulated by activated m1 MAChR (Fig. 4A). Since
G11aX and G16aX did not affect the activation of PLCb2 by bg
in COS-7 cells, the inhibition of m1 MAChR-stimulation PLCb
activation by G11aX and G16aX most probably results from the
competitive binding of the mutant proteins to the receptor. In
similar experiments using G11aDN and G16aDN, we found that
they inhibited the activation of m1 MAChR as well as G11aX
and G16aX (Fig. 4A), suggesting that G11aDN and G16aDN
could also bind to m1 MAChR, although they do not bind either
FIG. 4. Empty mutants of G11a and G16a inhibited appropriate receptors in COS-7 cells. 1 3 10
5 cells/well were seeded in a 12-well plate
and then transfected with m1 MAChR (A), TRH receptor (B), thrombin receptor (C), or m2 MAChR (D) and indicated Ga. In A–C, the amount of
receptor cDNA for each well was 0.25 mg, and the amount of Ga was 0.75 mg. In D, the amount of both m2 MAChR and G15a cDNA was 0.2 mg/well
and that of mutant Ga was 0.6 mg/well. After cells were labeled with [3H]inositol overnight, they were incubated for 30 min in the medium
containing 1 mM carbachol (A and D), 1 mM TRH (B), or 0.1 unit/ml thrombin (C) before levels of inositol phosphates were determined.
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guanine nucleotides or xanthine nucleotides. In the experi-
ments with two other Gq-coupled receptors, TRH receptor and
thrombin receptor (14–16), we found that all four mutant pro-
teins were able to inhibit activation by receptors (Fig. 4, B and
C). These results agree with our previous observation that the
empty Goa mutant protein forms a stable complex with appro-
priate receptor. Thus our working hypothesis is that in the
absence of xanthine nucleotides sufficient levels of mutant
proteins are made to interact with the appropriate receptors.
Empty GoaX mutants appear to retain the receptor binding
specificity of wild-type Goa (6). To test whether empty G11a and
G16a mutants also behave similarly, we assayed for their inhi-
bition of activation by the m2 MAChR, a member of Gi-coupled
receptor family. Since m2 MAChR couples only to the Gi family
of Ga proteins, but not to the Gq family (4, 9), we could not
assay the activity of m1 MAChR by monitoring Gqa-stimulated
PLCb activities in COS-7 cells. Therefore we constructed an
artificial pathway by cotransfecting both m2 MAChR and G15a
into COS-7 cells. G15a and G16a are homologous proteins (G15
mouse and G16 human) that behave as a promiscuous G pro-
tein, which can be activated by all kinds of G protein-coupled
receptors, and activated G15 stimulates the activity of PLCb
(4). In cells cotransfected with both m2 MAChR and G15a, we
were able to activate endogenous PLCb isoforms by the addi-
tion of the muscarinic agonist carbachol. In the cotransfection
experiments with m2 MAChR, G15a, and the empty mutants of
G11a and G16a, we found that only G16aX and G16aDN inhib-
ited activation by m2 MAChR, whereas G11aX and G11aDN
had no effect (Fig. 4D). This is consistent with the fact that
G11a does not couple to the m2 MAChR and G16a does. These
experiments suggest that both empty mutants of G11a and
G16a retain the binding specificity of their wild-type counter-
parts; G11aX and G11aDN only interact with Gq-coupled recep-
tors, but not with Gi-coupled receptor, whereas G16aX and
G16aDN can interact with both families of receptors.
Inhibition of Endogenous Thrombin Receptor and LPA Re-
ceptor in NIH3T3 Cells—NIH3T3 cells express endogenous
thrombin receptors and LPA receptors (17). These two types of
receptors couple to a variety of G proteins, including Gi, Gq, and
G12/13 (16, 18). Activation of these receptors leads to the acti-
vation of serum response factor (SRF) and SRF-mediated gene
transcription through RhoA, via both the Gq and G12/13 path-
ways presumably. To investigate whether empty Ga mutants
inhibit thrombin receptor and LPA receptor in NIH3T3 cells,
we determined the activity of luciferase, whose expression was
under the regulation of SRE.L, when the cells were cotrans-
fected with the mutant G proteins and the reporter gene plas-
mid. SRE.L is a derivative of the c-Fos serum response element
(SRE) to which SRF binds and activates luciferase transcrip-
tion (19). We found that the empty mutants of all three types of
a subunits, Goa, G11a, and G16a, were able to inhibit the
activation of both thrombin receptors (Fig. 5A) and LPA recep-
tors (Fig. 5B). These results are consistent with the experi-
ments in COS-7 cells showing that the empty G proteins bind
tightly to their cognate receptors. To exclude the possibility
that empty Ga mutants interfere with the downstream compo-
nents of the signaling pathway, we cotransfected the cells with
the constitutively activate Gq mutant, GqaQL, and the empty
Ga mutants. We found that the empty Ga mutants did not
affect GqaQL-stimulated SRF activation (data not shown), in-
dicating that the inhibition of receptor-stimulated SRF activa-
tion by empty Ga mutants must come from their competitive
binding to the receptor, not from direct Ga activation of down-
stream effectors.
NIH3T3 cells apparently do not have endogenous muscarinic
receptors, since addition of carbachol did not lead to the acti-
vation of SRF (17). We transfected the cells with m1 MAChR
and found that its activation resulted in stimulated luciferase
activity, presumably through the endogenous Gq pathway. Co-
FIG. 5. Empty mutants of Goa, G11a, and G16a inhibited endog-
enous thrombin and LPA receptors in NIH3T3 cells. 1 3 105
cells/well were seeded in a 24-well plate and then transfected with 0.2
mg of SRF-luciferase reporter plasmid cDNA and 0.75 mg of indicated
Ga mutant cDNA (A and B) or 0.2 mg of SRF-luciferase reporter plasmid
cDNA, 0.2 mg of m1 MAChR cDNA, and 0.5 mg of indicated Ga mutant
cDNA (C). After 24-h starvation, cells were stimulated with 0.5 mM LPA
(A), 1 unit/ml thrombin (B), or 1 mM carbachol (C) for 6 h before the
activity of luciferase was determined.
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expression of the Ga mutants showed that G11aX, G11aDN,
G16aX, and G16aDN inhibited the activation of m1 MAChR, but
GoaX and GoaDN did not. These experiments indicate that the
presumptive empty form of G11a and G16a bound m1 MAChR
whereas the empty form of Goa did not, consistent with the
results from COS-7 cell experiments.
DISCUSSION
We previously reported that GoaX, the xanthine nucleotide-
binding mutant protein of Goa, formed stable complexes with
their appropriate receptors and inhibited the activation of cog-
nate receptors because of competitive binding (6). In this study,
we reconstituted GoaX, Goa, bg, and m2 MAChR and Sf9 cell
membranes. We monitored the GTPgS binding of Goa facili-
tated by m2 MAChR upon the activation of its agonist carba-
chol. Not surprisingly, we found that GoaX inhibited the nu-
cleotide exchange of wild-type Goa catalyzed by the activated
m2 MAChR. Therefore, we demonstrated that GoaX was able to
inhibit the activation of m2 MAChR in vitro.
To extend this work to other families of G proteins, we
introduced the similar DN mutation in wild-type G11a and
G16a, as well as activated G11aQL and G16aQL, and expressed
the mutant proteins in COS-7 cells. After immunoprecipitating
the mutant proteins incubated with radioactive nucleotides in
COS-7 cell lysates, we found that G11aX and G16aX bound
XTPgS instead of GTPgS, whereas wild-type G11a and G16a
preferred GTPgS. However, G11aDN and G16aDN did not ap-
pear to bind either nucleotides. We also showed that the mu-
tant proteins of G11aX and G16aX expressed in COS-7 cells
interacted with bg subunits in a XDP-dependent fashion; they
only bound bg when XDP was available, whereas G11aDN and
G16aDN did not. These results are consistent with previous
findings using GoaX and GoaDN; the single DN mutation re-
sulted in a loss of ability to bind nucleotides, whereas the
double DN/QL mutation lead to xanthine nucleotide binding
(5). Although the mutation of Asp 3 Asn in the conserved
NKXD motif of G protein a subunits was expected to switch the
nucleotide specificity of the mutated protein from guanine nu-
cleotide to xanthine nucleotide, according to the available crys-
tal structures of G protein a subunits and other GTP-binding
proteins, we observed that the single DN mutation resulted in
a protein not able to bind either nucleotides in three G protein
a subunits: Goa, G11a, and G16a. It is not apparent from the
crystal structures why the second QL mutation, a well charac-
terized GTPase-deficient mutation, restored the xanthine nu-
cleotide binding of the mutant proteins; the conserved Gln
(position 200 in transducin a) resides at the opposite side of the
nucleotide binding pocket from the DN mutation (position 268
in transducin a).
To test whether empty mutants of G11a and G16a interacted
with G protein-coupled receptors and inhibited the activation of
appropriate receptors, we assayed the stimulated PLCb activ-
ity by transfected receptors in COS-7 cells and the activation of
SRF by endogenous thrombin receptors and LPA receptors in
NIH3T3 cells. We found that G11aX and G16aX inhibited the
activation of m1 of MAChR and TRH receptor, but not m2
MAChR, whereas GoaX and GoaDN inhibited the activation of
m2 MAChR, but not m1 MAChR or TRH receptor. Further-
more, G16aX and G16aDN were found to inhibit the activation
of m1 MAChR, TRH receptor, and m2 MAChR, in addition to
that GoaX, GoaDN, G11aX, G11aDN, G16aX, and G16aDN were
all able to inhibit the activation of thrombin receptors and LPA
receptors. Therefore, we conclude that these empty mutants of
G protein a subunits retain the same receptor binding speci-
ficity of their wild-type counterparts. Empty Goa interacts with
only Gi-coupled receptors, and empty G11a interacts with only
Gq-coupled receptors, while G16a can interact with both fami-
lies of G protein-coupled receptors. It is interesting to note that
G11aDN and G16aDN were able to inhibit the activation of
their appropriate receptors as effectively as G11aX and G16aX,
although G11aDN and G16aDN did not bind xanthine nucleo-
tides. Similarly, GoaDN was shown to interact with receptors
but not able to bind nucleotides (5, 6). These experiments
proved that the empty mutant forms of these G protein a
subunits can act as effective dominant negative inhibitors
against a subset of G protein-coupled receptors. They can be
very useful tools to dissect signaling pathways of different G
protein-coupled receptors by specifically blocking one family of
receptors.
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